Synthesis of lasofoxifene, nafoxidine and their positional isomers via the novel three-component coupling reaction

Molecules

Volumn 15, Issue 10, 2010, Pages 6773-6794

  Nakata, Kenya ^a   Sano, Yoshiyuki ^a   Shiina, Isamu ^a  

^a TOKYO UNIVERSITY OF SCIENCE   (Japan)

Author keywords

Diversity oriented synthesis; Inv lasofoxifene; Inv nafoxidine; Lasofoxifene; Nafoxidine; Three component coupling reaction

Indexed keywords

EID: 78149457902     PISSN: None     EISSN: 14203049     Source Type: Journal    
DOI: 10.3390/molecules15106773     Document Type: Article

References (43)

1. Ugi, I. Recent progress in the chemistry of multicomponent reactions. Pure Appl. Chem. 2001, 73, 187-191.
2. Hulme, C. In Muticomponent Reactions; Zhu, J., Bienayme, H., Eds.; Wiley-VCH: Weinheim, 2005; pp. 311-341.
3. Eckert, H. From multi-component-reactions (MCRs) towards multi-function-component-reactions (MFCRs). Heterocycles 2007, 73, 149-158.
4. Ugi, I. Isonitrile Chemistry; Academic Press: New York, NY, USA/London, UK, 1971.
5. Doemling A.; Ugi, I. Multicomponent reactions with isocyanides. Angew. Chem. Int. Ed. 2000, 39, 3168-3210.
6. Wang, Z.; Zhou, L.; El-Boubbou, K.; Ye, X.; Huang, X. Multi-component one-pot synthesis of the tumor-associated carbohydrate antigen Globo-H based on preactivation of thioglycosyl donors. J. Org. Chem. 2007, 72, 6409-6420.
7. Hashihayata, T.; Ikegai, K.; Takeuchi, K.; Jona H.; Mukaiyama, T. Convergent total syntheses of oligosaccharides by one-pot sequential stereoselective glycosylations. Bull. Chem. Soc. Jpn. 2003, 76, 1829-1848.
8. D'Souza D.M.; Müller, T.J.J. Multi-component syntheses of heterocycles by transition-metal catalysis. Chem. Soc. Rev. 2007, 36, 1095-1108.
9. Perreault S.; Rovis, T. Multi-component cycloaddition approaches in the catalytic asymmetric synthesis of alkaloid targets. Chem. Soc. Rev. 2009, 38, 3149-3159.
10. Shiina, I.; Suzuki, M.; Yokoyama, K. A convenient method for the synthesis of 4,4-diarylbut-1- enes via the successive allylation of aromatic aldehydes and the Friedel-Crafts alkylation reaction of aromatic nucleophiles with the intermediary benzyl silyl ethers using HfCl4 or Cl2Si(OTf)2. Tetrahedron Lett. 2002, 43, 6395-6398.
11. Shiina, I.; Suzuki, M. The catalytic Friedel-Crafts alkylation reaction of aromatic compounds with benzyl or allyl silyl ethers using Cl2Si(OTf)2 or Hf(OTf)4. Tetrahedron Lett. 2002, 43, 6391-6394.
12. Ke, H.Z.; Chen, H.K.; Simmons, H.A.; Qi, H.; Crawford, D.T.; Pirie, C.M.; Chidsey-Frink, K.L.; Ma, Y.F.; Jee, W.S.; Thompson, D.D. Comparative effects of droloxifene, tamoxifen, and estrogen on bone, serum cholesterol, and uterine histology in the ovariectomized rat model. Bone 1997, 20, 31-39.
13. McDonnell, D.P. The molecular pharmacology of SERMs. Trends Endocrinol. Metab. 1999, 10, 301-311.
14. Lonard, D.M.; Smith, C.L. Molecular perspectives on selective estrogen receptor modulators (SERMs): Progress in understanding their tissue-specific agonist and antagonist actions. Steroids 2002, 67, 15-24.
15. Jordan, V.C. Antiestrogens and selective estrogen receptor modulators as multifunctional medicines. 2. Clinical considerations and new agents. J. Med. Chem. 2003, 46, 1081-1111.
16. Shiina, I.; Suzuki, M.; Yokoyama, K. Short-step synthesis of tamoxifen and its derivatives via the three-component coupling reaction and migration of the double bond. Tetrahedron Lett. 2004, 45, 965-967.
17. Shiina, I.; Sano, Y.; Nakata, K.; Suzuki, M.; Yokoyama, T.; Sasaki, A.; Orikasa, T.; Miyamoto, T.; Ikekita, M.; Nagahara, Y.; Hasome, Y. An expeditious synthesis of tamoxifen, a representative SERM (selective estrogen receptor modulator), via the three-component coupling reaction among aromatic aldehyde, cinnamyltrimethylsilane and b-chlorophenetole. Bioorg. Med. Chem. 2007, 15, 7599-7617.
18. Sano, Y.; Shiina, I. Short-step synthesis of droloxifene via the three-component coupling reaction among aromatic aldehyde, cinnamyltrimethylsilane, and b-chlorophenetole. Tetrahedron Lett. 2006, 47, 1631-1635.
19. Sano, Y.; Nakata, K.; Otoyama, T.; Umeda, S.; Shiina, I. An expeditious synthesis of lasofoxifene and nafoxidine via the novel three-component coupling reaction. Chem. Lett. 2007, 36, 40-41.
20. Shiina, I.; Sano, Y.; Nakata, K.; Kikuchi, T.; Sasaki, A.; Ikekita, M.; Hasome, Y. Synthesis of the new pseudo-symmetrical tamoxifen derivatives and their anti-tumor activity. Bioorg. Med. Chem. Lett. 2007, 17, 2421-2424.
21. Shiina, I.; Sano, Y.; Nakata, K.; Kikuchi, T.; Sasaki, A.; Ikekita, M.; Nagahara, Y.; Hasome, Y.; Yamori, T.; Yamazaki, K. Synthesis and pharmacological evaluation of the novel pseudosymmetrical tamoxifen derivatives as anti-tumor agents. Biochem. Pharmacol. 2008, 75, 1014-1026.
22. Nagahara, Y.; Shiina, I.; Nakata, K.; Sasaki, A.; Miyamoto, T.; Ikekita, M. Induction of mitochondria-involved apoptosis in estrogen receptor negative cells by a novel tamoxifen derivative, Ridaifen B. Cancer Sci. 2008, 99, 608-614.
23. Kumar, S.; Kumar, V.; Chimni, S.S. Novel indium-mediated ternary reactions between indole-3- carboxaldehydes-allyl bromide-enamines: facile synthesis of bisindolyl- and indolyl-heterocyclic alkanes. Tetrahedron Lett. 2003, 44, 2101-2104.
24. Roy, U.K.; Jana, P.K.; Roy, S. Pd0/SnII mediated three-component cascade coupling (3-C3) approaches. Tetrahedron Lett. 2007, 48, 1183-1186.
25. Zhao, X.-L.; Liu, L.; Chen, Y.-J.; Wang, D. Three-component Barbier allylation, Friedel-Crafts alkylation and intramolecular hydroalkoxylation in an ionic liquid for the direct synthesis of 4- arylchromans. Synlett 2007, 9, 1357-1364.
26. Zhao, X.-L.; Liu, L.; Chen, Y.-J.; Wang, D. Three-component Barbier allylation-Friedel-Crafts alkylation promoted by BuPyCl/SnCl2•2H2O: Application to the synthesis of 4-(substituted phenyl)chromans. Chin. J. Chem. 2007, 25, 1312-1322.
27. Ke, H.Z.; Qi, H.; Crawford, D.T.; Chidsey-Frink, K.L.; Simmons, H.A.; Thompson, D.D. Lasofoxifene (CP-336,156), a selective estrogen receptor modulator, prevents bone loss induced by aging and orchidectomy in the adult rat. Endocrinology 2000, 141, 1338-1344.
28. Gennari, L.; Merlotti, D.; Valleggi, F.; Martini, G.; Nuti, R. Selective estrogen receptor modulators for postmenopausal osteoporosis - Current state of development. Drugs Aging 2007, 24, 361-379.
29. De Lorenzo, M.S.; Alonso, D.F.; Gomez, D.E. Nafoxidine modulates the expression of matrixmetalloproteinase- 2 (MMP-2) and tissue inhibitor of metalloproteinases-1 (TIMP-1) in endothelial cells. Anticancer Res. 2000, 20, 395-400.
30. Lednicer, D.; Babcock, J.C.; Lyster, S.C.; Duncan, G.W. Derivatives of 1,2-diphenyl-3,4- dihydronaphthalene as antifertility agents. Chem. Ind. (London) 1963, 408-409.
31. Lednicer, D.; Lyster, S.C.; Aspergren, B.D.; Duncan, G.W. Mammalian antifertility agents. III. 1- Aryl-2-phenyl-1,2,3,4-tetrahydro-1-naphthols, 1-atyl-2-phenyl-3,4-dihydronaphthalenes, and their derivatives. J. Med. Chem. 1966, 9, 172-176.
32. Lednicer, D.; Lyster, S.C.; Duncan, G.W. Mammalian antifertility agents. IV. Basic 3,4- dihydronaphthalenes and 1,2,3,4-tetrahydro-1-naphthols. J. Med. Chem. 1967, 10, 78-84.
33. Lednicer, D.; Emmert, D.E.; Lyster, S.C.; Duncan, G.W. Mammalian antifertility agents. VI. A novel sequence for the preparation of 1,2-disubstituted 3,4-dihydronaphthalenes. J. Med. Chem. 1969, 12, 881-885.
34. Cameron, K.O.; Jardine, P.A.D. Preparation of 5-[4-(2-heterocyclylethoxy) phenyl]-5,6,7,8- tetrahydronaphthalene-2-ols and 1-[4-(2-heterocyclylethoxy) phenyl]-6-hydroxy-1,2,3,4-tetrahydroisoquinolines as estrogen agonists/antagonists. WO9621656, 1996; [Chem. Abstr. 1996, 125, 195446].
35. Rosati, R.L.; Jardine, P.D.; Cameron, K.O.; Thompson, D.D.; Ke, H.Z.; Toler, S.M.; Brown, T.A.; Pan, L.C.; Ebbinghaus, C.F.; Reinhold, A.R.; Elliott, N.C.; Newhouse, B.N.; Tjoa, C.M.; Sweetnam, P.M.; Cole, M.J.; Arriola, M.W.; Gauthier, J.W.; Crawford, D.T.; Nickerson, D.F.; Pirie, C.M.; Qi, H.; Simmons, H.A.; Tkalcevic, G.T. Discovery and preclinical pharmacology of a novel, potent, nonsteroidal estrogen receptor agonist/antagonist, CP-336156, a diaryltetrahydronaphthalene. J. Med. Chem. 1998, 41, 2928-2931.
36. Chu, C.K.F. Preparation of cis-1-[2-[4-(6-methoxy-2-phenyl-1,2,3,4- tetrahydronaphthalen-1- yl)phenoxy]ethyl]pyrrolidine as intermediate for antiosteoporotic agent. JP2000327670, 2000; [Chem. Abstr. 2001, 134, 4858].
37. Edstrom, E.D.; Livinghouse, T. New methods for the generation of episulfonium ions. An application to the synthesis of carbocycles via sulfenium ion promoted arene-alkene cyclizations. J. Am. Chem. Soc. 1986, 108, 1334-1336.
38. Edstrom, E.D.; Livinghouse, T. On the direct generation of episelenonium ions from alkenes. An efficient new procedure for effecting selenylative arene-alkene carboannulations. Tetrahedron Lett. 1986, 27, 3483-3486.
39. Barluenga, J.; González, J.M.; Campos, P.J.; Asensio, G. I(Py)2BF4, a new reagent in organic synthesis: General method for the 1,2-iodofunctionalization of olefins. Angew. Chem. Int. Ed. 1985, 24, 319-320.
40. Barluenga, J.; González, J.M.; Campos, P.J.; Asensio, G. Iodine-induced stereoselective carbocyclizations: A new method for the synthesis of cyclohexane and cyclohexene derivatives. Angew. Chem. Int. Ed. 1988, 27, 1546-1547.
41. Appelbe, R.; Casey, M.; Dunne, A.; Pascarella, E. Stereoselective synthesis of tetralins using cationic cyclisations. Tetrahedron Lett. 2003, 44, 7641-7644.
42. Homsi, F.; Robin, S.; Rousseau, G. Preparation of bis(2,4,6- trimethylpyridine)iodine(I) hexafluorophosphate and bis(2,4,6-trimethylpyridine) bromine(I) hexafluorophosphate. Org. Synth. 2000, 77, 206-208.
43. Bindal, R.D.; Durani, S.; Kapil, R.S.; Anand, N. Utility of 4-trimethylsiloxyphenylmagnesium bromide in grignard reactions. Synthesis 1982, 405-407.